Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Rea, D.W.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(15)
+
-
Availability
Open access
(3)
+
-
Metadata Only
(12)
+
-
Creation Date
2016
(4)
+
-
2013
(2)
+
-
2014
(2)
+
-
2015
(2)
+
-
2017
(2)
+
-
2018
(2)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(15)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(15)
+
-
Author
Rea, D.W.
(15)
+
-
Velde, C.J.H. van de
(15)
+
-
Bartlett, J.M.S.
(14)
+
-
Seynaeve, C.
(14)
+
-
Hasenburg, A.
(12)
+
-
Brookes, C.L.
(9)
+
-
Kieback, D.G.
(8)
+
-
Markopoulos, C.
(8)
+
-
Putter, H.
(8)
+
-
Dirix, L.Y.
(5)
+
-
Bayani, J.
(4)
+
-
Dirix, L.
(4)
+
-
Mallon, E.A.
(4)
+
-
Markopoulos, C.J.
(4)
+
-
Piper, T.
(4)
+
-
Quintayo, M.A.
(4)
+
-
Boutros, P.C.
(3)
+
-
Drake, C.
(3)
+
-
Haider, S.
(3)
+
-
Kranenbarg, E.M.K.
(3)
+
-
Liefers, G.J.
(3)
+
-
Nortier, J.W.R.
(3)
+
-
Sabine, V.S.
(3)
+
-
Yao, C.Q.
(3)
+
-
Ahmed, I.
(2)
+
-
Blok, E.J.
(2)
+
-
Crozier, C.
(2)
+
-
Cuzick, J.
(2)
+
-
Dell'Orto, P.
(2)
+
-
Derks, M.G.M.
(2)
+
-
Dowsett, M.
(2)
+
-
Forbes, J.F.
(2)
+
-
Hozumi, Y.
(2)
+
-
Kroep, J.R.
(2)
+
-
Paridaens, R.
(2)
+
-
Regan, M.M.
(2)
+
-
Sestak, I.
(2)
+
-
Translational Aromatase Inhibitor
(2)
+
-
Vannetzel, J.M.
(2)
+
-
Viale, G.
(2)
+
-
Show more
Language
en
(15)
+
-
Search results
(1 - 15 of 15)
show grid
show list
save search
Overestimation of late distant recurrences in high-risk patients with ER-positive breast cancer
Pathway-based subnetworks enable cross-disease biomarker discovery
Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial
HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2
10-year follow-up and biomarker discovery for adjuvant endocrine therapy; results of the TEAM trial
Age at diagnosis and breast cancer outcomes after ten years of follow up among postmenopausal women with hormone receptor positive breast cancer
HER2 status as predictive marker for Al vs Tam benefit: A TRANS-AIOG meta-analysis of 12129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2
Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trial
Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial
Does androgen receptor (AR) expression impact on residual risk? A TEAM pathology study
Theranostic multiparametric tests improve residual risk assessment in early luminal breast cancer
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial
Specific Adverse Events Predict Survival Benefit in Patients Treated With Tamoxifen or Aromatase Inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial Analysis